BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8254759)

  • 1. Identification of an 80-kilodalton membrane glycoprotein important for human T-cell leukemia virus type I and type II syncytium formation and infection.
    Agadjanyan MG; Ugen KE; Wang B; Williams WV; Weiner DB
    J Virol; 1994 Jan; 68(1):485-93. PubMed ID: 8254759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies define a cellular antigen involved in HTLV-I infection.
    Agadjanyan MG; Chattergoon MA; Petrushina I; Bennett M; Kim J; Ugen KE; Kieber-Emmons T; Weiner DB
    Hybridoma; 1998 Feb; 17(1):9-19. PubMed ID: 9523233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II-induced cell fusion.
    Wang B; Agadjanyan MG; Srikantan V; Ugen KE; Hall W; Kaplan MH; Dang K; Williams WV; Weiner DB
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):849-60. PubMed ID: 8257634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells.
    Fukudome K; Furuse M; Imai T; Nishimura M; Takagi S; Hinuma Y; Yoshie O
    J Virol; 1992 Mar; 66(3):1394-401. PubMed ID: 1738199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a domain within the human T-cell leukemia virus type 2 envelope required for syncytium induction and replication.
    Poon B; Chen IS
    J Virol; 1998 Mar; 72(3):1959-66. PubMed ID: 9499049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syncytium-inhibiting monoclonal antibodies produced against human T-cell lymphotropic virus type 1-infected cells recognize class II major histocompatibility complex molecules and block by protein crowding.
    Hildreth JE
    J Virol; 1998 Dec; 72(12):9544-52. PubMed ID: 9811687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of human T-lymphotropic virus type I- and II-infected T-cell lines: antigenic, phenotypic, and genotypic analysis.
    Dezzutti CS; Rudolph DL; Roberts CR; Lal RB
    Virus Res; 1993 Jul; 29(1):59-70. PubMed ID: 8105609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syncytium formation by recombinant HTLV-II envelope glycoprotein.
    Li QX; Camerini D; Xie Y; Greenwald M; Kuritzkes DR; Chen IS
    Virology; 1996 Apr; 218(1):279-84. PubMed ID: 8615036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusion activity dissociated from replication ability in feline immunodeficiency virus (FIV) in human cells.
    Tochikura TS; Tanabe-Tochikura A; Hayes KA; Lazo A; Bailer RT; Blakeslee JR; Lafrado LJ; Roy-Burman P; Pandey R; Olsen RG
    J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1301-10. PubMed ID: 8254466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 71-kilodalton heat shock cognate protein acts as a cellular receptor for syncytium formation induced by human T-cell lymphotropic virus type 1.
    Sagara Y; Ishida C; Inoue Y; Shiraki H; Maeda Y
    J Virol; 1998 Jan; 72(1):535-41. PubMed ID: 9420256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of plating of human T cell leukemia virus type I and syncytium-inducing types of human immunodeficiency virus type 1 by polycations.
    Haraguchi Y; Takeuchi Y; Hoshino H
    AIDS Res Hum Retroviruses; 1997 Nov; 13(17):1517-23. PubMed ID: 9390751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human T-cell leukaemia/lymphoma virus type 1 syncytium formation is regulated in a cell-specific manner by ICAM-1, ICAM-3 and VCAM-1 and can be inhibited by antibodies to integrin beta2 or beta7.
    Daenke S; McCracken SA; Booth S
    J Gen Virol; 1999 Jun; 80 ( Pt 6)():1429-1436. PubMed ID: 10374960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of CD8+ T-cells producing a strong cytopathic effect on CD4+ T-cells through syncytium formation by HTLV-II.
    Miyamoto K; Kamiya T; Minowada J; Tomita N; Kitajima K
    Jpn J Cancer Res; 1991 Nov; 82(11):1178-83. PubMed ID: 1752776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of virus production and induction of self-syncytium formation in human T-cell leukemia virus type I- and type II-infected T cells by 12-O-tetradecanoylphorbol-13-acetate.
    Wolfson M; Lev M; Avinoah I; Malik Z; Löchelt M; Flügel RM; Dombrovski A; Aboud M
    J Virol; 1994 Jul; 68(7):4695-9. PubMed ID: 8207847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of membrane antigens important for adsorption of human T-cell leukaemia virus type I.
    Fu DX; Haraguchi Y; Jinno A; Yang D; Hoshino H
    Res Virol; 1998; 149(6):383-92. PubMed ID: 9923014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human lymphotropic retroviruses associated with mycosis fungoides: evidence that human T-cell lymphotropic virus type II (HTLV-II) as well as HTLV-I may play a role in the disease.
    Zucker-Franklin D; Hooper WC; Evatt BL
    Blood; 1992 Sep; 80(6):1537-45. PubMed ID: 1520878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock cognate protein 70 is a cell fusion-enhancing factor but not an entry factor for human T-cell lymphotropic virus type I.
    Fang D; Haraguchi Y; Jinno A; Soda Y; Shimizu N; Hoshino H
    Biochem Biophys Res Commun; 1999 Aug; 261(2):357-63. PubMed ID: 10425190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of synapse-associated protein Dlg1 reduces syncytium formation induced by human T-cell leukemia virus type 1.
    Yoshida S; Higuchi M; Shoji T; Yoshita M; Ishioka K; Takahashi M; Oie M; Tanaka Y; Uchiyama M; Fujii M
    Virus Genes; 2008 Aug; 37(1):9-15. PubMed ID: 18461433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of inhibitory effect of dextran sulfate and heparin on human T-cell lymphotropic virus type I (HTLV-I)-induced syncytium formation in vitro: role of cell-to-cell contact.
    Ida H; Kurata A; Eguchi K; Yamashita I; Nakashima M; Sakai M; Kawabe Y; Nakamura T; Nagataki S
    Antiviral Res; 1994 Feb; 23(2):143-59. PubMed ID: 7908510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of glucose transporter 1 confers susceptibility to human T-cell leukemia virus envelope-mediated fusion.
    Coskun AK; Sutton RE
    J Virol; 2005 Apr; 79(7):4150-8. PubMed ID: 15767416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.